我院2005～2008年抗肿瘤药及抗肿瘤辅助药利用分析

目的:了解我院抗肿瘤药及抗肿瘤辅助药的应用情况。方法:采用回顾性调查方法,对我院2005～2008年抗肿瘤药及抗肿瘤辅助药的出库数量、销售金额、构成比等进行统计、分析。结果:我院抗肿瘤药及抗肿瘤辅助药应用一直位居前列,各年度销售金额占西药总销售金额的比例分别为25.91%、28.16%、31.16%和33.00%,呈逐年增长趋势;剂型多为注射剂,各年度分别占抗肿瘤药总品种的75.40%、79.80%、80.50%和78.12%;国产药占绝对优势。结论:我院应进一步规范抗肿瘤药及抗肿瘤辅助药应用,促使用药更加安全、有效、经济。

Utilization of Antineoplastic Drugs and Adjuvant Drugs in Our Hospital During the Period 2005-2008

OBJECTIVE： To investigate the utilization of antineoplastic drugs and adjuvant drugs in our hospital. METHODS： By a retrospective review, the consumption quantity, consumption sum, and constituent ratio of antineoplastic drugs and adjuvant drugs used in our hospital from 2005 to 2008 were analyzed statistically. RESULTS： The consumption of antineoplastic drugs and assistant drugs had dominated the front places from 2005 to 2008, representing 25.91%, 28.16%, 31.16% and 33.00%, respectively of the total western drugs in terms of consumption sum, assuming a year-on-year increase tendency over the 4 years. Injections took a higher proportion, making up for 75.40%, 79.80%, 80.50% and 78.12%, re- spectively over the 4 years. The application of antineoplastic drugs and assistant drugs from domestic manufacturers assumed a predominant place. CONCLUSION： It is still necessary to standardize the use of antineoplastic drugs and assistant drugs in our hospital so as to ensure their safety, effectiveness and economy in clinical medication.